ACADIA Pharmaceuticals. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 83.07. In total, the insiders bought 2 316 024 and sold 206 624 ACAD shares in the last 100 trades.

Insider Power

(Last 100 transactions)
83.07
Buy 2 316 024 Shares
Sell 206 624 Shares

Historical Insider Trades

Date Type Action Person Amount
May 02, 2025 Common Stock Sell Kihara James 1 327
May 02, 2025 Common Stock Sell Schneyer Mark C. 3 498
May 01, 2025 Common Stock Buy Kihara James 2 596
May 01, 2025 Restricted Stock Units Sell Kihara James 2 596
May 01, 2025 Common Stock Buy Schneyer Mark C. 6 815
May 01, 2025 Restricted Stock Units Sell Schneyer Mark C. 6 815
Apr 08, 2025 Common Stock Sell Schneyer Mark C. 2 708
Apr 08, 2025 Common Stock Sell Kihara James 1 028
Apr 05, 2025 Common Stock Buy Schneyer Mark C. 5 275
Apr 05, 2025 Restricted Stock Units Sell Schneyer Mark C. 5 275
Apr 05, 2025 Common Stock Buy Kihara James 2 010
Apr 05, 2025 Restricted Stock Units Sell Kihara James 2 010
Mar 26, 2025 Common Stock Sell Kihara James 1 095
Mar 26, 2025 Common Stock Sell Schneyer Mark C. 3 171
Mar 25, 2025 Common Stock Buy Kihara James 2 142
Mar 25, 2025 Restricted Stock Units Sell Kihara James 2 142
Mar 25, 2025 Common Stock Buy Schneyer Mark C. 6 178
Mar 25, 2025 Restricted Stock Units Sell Schneyer Mark C. 6 178
Mar 24, 2025 Stock Option (Right to Buy) Buy Kihara James 22 152
Mar 24, 2025 Restricted Stock Units Buy Kihara James 6 510
Mar 24, 2025 Stock Option (Right to Buy) Buy Schneyer Mark C. 110 761
Mar 24, 2025 Restricted Stock Units Buy Schneyer Mark C. 32 552
Mar 24, 2025 Stock Option (Right to Buy) Buy Rhodes Jennifer J 102 289
Mar 24, 2025 Restricted Stock Units Buy Rhodes Jennifer J 30 062
Mar 24, 2025 Stock Option (Right to Buy) Buy Thompson Elizabeth H.z. 91 395
Click to get the best stock tips daily for free!
ABOUT ACADIA PHARMACEUTICALS INC.
ACADIA Pharmaceuticals.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych...
GOLDEN STAR
Ticker Change Signal Date
JLL
$229.63
2.57% May 09
UAA
$5.84
11.99% May 09
IIPR
$54.61
1.54% May 09
IEP
$8.75
10.51% May 09
BAX
$30.72
1.04% May 07

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE